Evidence map›Paper›PMID 25693050›Full record

Trial reportPloS one2015

An augmented SMS intervention to improve access to antenatal CD4 testing and ART initiation in HIV-infected pregnant women: a cluster randomized trial.

Scott Dryden-Peterson, Kara Bennett, Michael D Hughes, Adrian Veres, Oaitse John, Rosina Pradhananga, Matthew Boyer, Carolyn Brown, Bright Sakyi, Erik van Widenfelt and 8 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 6 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 6 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Review
  10. Article
  11. Article
  12. Recommendations for Developing a Telemedicine Strategy for Botswana: A Meta-Synthesis.International journal of environmental research and public health · 2023
    Article
  13. Review
  14. Review
  15. Article
  16. Lack of Virological Suppression Among Young HIV-Positive Adults in Botswana.Journal of acquired immune deficiency syndromes (1999) · 2018
    Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 2 countries.

Scott Dryden-PetersonDivision of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, United States of America; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America; Harvard Medical School, Boston, Massachusetts, United States of America.
Kara BennettBennett Statistical Consulting, Inc., Ballston Lake, New York, United States of America.
Michael D HughesDepartment of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America.
Adrian VeresHarvard Medical School, Boston, Massachusetts, United States of America.
Oaitse JohnBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Rosina PradhanangaYale School of Public Health, New Haven, Connecticut, United States of America.
Matthew BoyerJoan C. Edwards School of Medicine, Marshall University, Huntington, West Virginia, United States of America.
Carolyn BrownJohn's Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Bright SakyiMinistry of Health, Gaborone, Botswana.
Erik van WidenfeltBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Koona KeapoletsweMinistry of Health, Gaborone, Botswana.
Madisa MineMinistry of Health, Gaborone, Botswana.
Sikhulile MoyoBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Aida AsmelashBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Mark SiednerHarvard Medical School, Boston, Massachusetts, United States of America; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Mompati MmalaneBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Roger L ShapiroBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America; Harvard Medical School, Boston, Massachusetts, United States of America; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
Shahin LockmanDivision of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, United States of America; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America; Harvard Medical School, Boston, Massachusetts, United States of America.
Botswana Harvard AIDS Institute Partnership · BWHarvard University · USMinistry of Health · BWBeth Israel Deaconess Medical Center · USBrigham and Women's Hospital · USJohns Hopkins University · USMarshall University · USMassachusetts General Hospital · US

Funding

Maternal and Infant Health and HAART Outcomes in the Mashi PMTCT Study, BotswanaR01HD044391 · NICHD · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI LOCKMAN, SHAHIN · 2003 to 2010
$1.9M
Behavioral Aspects of Low-cost Medical Devices to Improve HIV CareK23MH099916 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI SIEDNER, MARK J · 2013 to 2017
$917k
Risk factors for early morbidity and mortality of HIV-exposed uninfected infantsK23AI091434 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI DRYDEN-PETERSON, SCOTT · 2012 to 2016
$659k
NIAID NIH HHS K23 AI091434NIAID NIH HHS K23AI091434NICHD NIH HHS 3R01HD044391-06S1NICHD NIH HHS R01 HD044391NIMH NIH HHS K23 MH099916
6 · The paper itself

Abstract

backgroundLess than one-third of HIV-infected pregnant women eligible for combination antiretroviral therapy (ART) globally initiate treatment prior to delivery, with lack of access to timely CD4 results being a principal barrier. We evaluated the effectiveness of an SMS-based intervention to improve access to timely antenatal ART.

methodsWe conducted a stepped-wedge cluster randomized trial of a low-cost programmatic intervention in 20 antenatal clinics in Gaborone, Botswana. From July 2011-April 2012, 2 clinics were randomly selected every 4 weeks to receive an ongoing clinic-based educational intervention to improve CD4 collection and to receive CD4 results via an automated SMS platform with active patient tracing. CD4 testing before 26 weeks gestation and ART initiation before 30 weeks gestation were assessed.

resultsThree-hundred-sixty-six ART-naïve women were included, 189 registering for antenatal care under Intervention and 177 under Usual Care periods. Of CD4-eligible women, 100 (59.2%) women under Intervention and 79 (50.6%) women under Usual Care completed CD4 phlebotomy before 26 weeks gestation, adjusted odds ratio (aOR, adjusted for time that a clinic initiated Intervention) 0.87 (95% confidence interval [CI]0.47-1.63, P = 0.67). The SMS-based platform reduced time to clinic receipt of CD4 test result from median of 16 to 6 days (P<0.001), was appreciated by clinic staff, and was associated with reduced operational cost. However, rates of ART initiation remained low, with 56 (36.4%) women registering under Intervention versus 37 (24.2%) women under Usual Care initiating ART prior to 30 weeks gestation, aOR 1.06 (95%CI 0.53-2.13, P = 0.87).

conclusionsThe augmented SMS-based intervention delivered CD4 results more rapidly and efficiently, and this type of SMS-based results delivery platform may be useful for a variety of tests and settings. However, the intervention did not appear to improve access to timely antenatal CD4 testing or ART initiation, as obstacles other than CD4 impeded ART initiation during pregnancy.

Indexed as

CD4 Lymphocyte CountPrenatal DiagnosisAdultAmbulatory Care FacilitiesAnti-HIV AgentsFemaleHealth Services AccessibilityHIV InfectionsHumansInfectious Disease Transmission, VerticalPhlebotomyPregnancyPregnancy Complications, InfectiousTelemedicineText MessagingTime FactorsAnti-HIV Agents

Identifiers

PMID25693050
PMCPMC4334487
OpenAlexW2105285524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.